Company Description

TollRAir is a start-up biotechnology company developing Tolarex, a novel patent-pending combination therapeutic targeting environmental toxin-induced nonallergic asthma (NA). Our therapy utilizes a firstin-class mechanism to target inflammation directly at the source, providing significant extended protection.